| An adenovirus mutant that replicates selectively in p53-deficient human tumor cells JR Bischoff, DH Kirn, A Williams, C Heise, S Horn, M Muna, L Ng, JA Nye, ... Science 274 (5286), 373-376, 1996 | 2381 | 1996 |
| A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers JR Bischoff, L Anderson, Y Zhu, K Mossie, L Ng, B Souza, B Schryver, ... The EMBO journal, 1998 | 1606 | 1998 |
| Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. JR Bischoff, PN Friedman, DR Marshak, C Prives, D Beach Proceedings of the National Academy of Sciences 87 (12), 4766-4770, 1990 | 525 | 1990 |
| A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations LI Toledo, M Murga, R Zur, R Soria, A Rodriguez, S Martinez, J Oyarzabal, ... Nature structural & molecular biology 18 (6), 721-727, 2011 | 517 | 2011 |
| The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis JR Bischoff, GD Plowman Trends in cell biology 9 (11), 454-459, 1999 | 476 | 1999 |
| Intermediate filament reorganization during mitosis is mediated by p34cdc2 phosphorylation of vimentin YH Chou, JR Bischoff, D Beach, RD Goldman Cell 62 (6), 1063-1071, 1990 | 411 | 1990 |
| Pten positively regulates brown adipose function, energy expenditure, and longevity A Ortega-Molina, A Efeyan, E Lopez-Guadamillas, M Muñoz-Martin, ... Cell metabolism 15 (3), 382-394, 2012 | 376 | 2012 |
| Bcl-2 associates with the ras-related protein R-rasp23 MJ Fernandez-Sarabia, JR Bischoff Nature 366 (6452), 274-275, 1993 | 356 | 1993 |
| Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. M Spaargaren, JR Bischoff Proceedings of the National Academy of Sciences 91 (26), 12609-12613, 1994 | 350 | 1994 |
| CDK inhibitors in cancer therapy: what is next? M Malumbres, P Pevarello, M Barbacid, JR Bischoff Trends in pharmacological sciences 29 (1), 16-21, 2008 | 341 | 2008 |
| Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines MG Callow, F Clairvoyant, S Zhu, B Schryver, DB Whyte, JR Bischoff, ... Journal of Biological Chemistry 277 (1), 550-558, 2002 | 337 | 2002 |
| p34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40 T antigen proteins. DA Jans, MJ Ackermann, JR Bischoff, DH Beach, R Peters The Journal of cell biology 115 (5), 1203-1212, 1991 | 269 | 1991 |
| BIRinging chromosomes through cell division—and survivin'the experience JC Reed, JR Bischoff Cell 102 (5), 545-548, 2000 | 191 | 2000 |
| Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. GF Morris, JR Bischoff, MB Mathews Proceedings of the National Academy of Sciences 93 (2), 895-899, 1996 | 188 | 1996 |
| A complex containing p34cdc2 and cyclin B phosphorylates the nuclear lamin and disassembles nuclei of clam oocytes in vitro. G Dessev, C Iovcheva-Dessev, JR Bischoff, D Beach, R Goldman The Journal of cell biology 112 (4), 523-533, 1991 | 180 | 1991 |
| The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion JH Wright, X Wang, G Manning, BJ LaMere, P Le, S Zhu, D Khatry, ... Molecular and cellular biology 23 (6), 2068-2082, 2003 | 148 | 2003 |
| Mechanism of interferon action activation of the human P1/eIF-2α protein kinase by individual reovirus s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA JR Bischoff, CE Samuel Virology 172 (1), 106-115, 1989 | 132 | 1989 |
| Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma MB Wozniak, R Villuendas, JR Bischoff, CB Aparicio, JFM Leal, ... Haematologica 95 (4), 613, 2010 | 117 | 2010 |
| Cellular resistance mechanisms to targeted protein degradation converge toward impairment of the engaged ubiquitin transfer pathway P Ottis, C Palladino, P Thienger, A Britschgi, C Heichinger, M Berrera, ... ACS chemical biology 14 (10), 2215-2223, 2019 | 114 | 2019 |
| PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma C Gomez-Abad, H Pisonero, C Blanco-Aparicio, G Roncador, ... Blood, The Journal of the American Society of Hematology 118 (20), 5517-5527, 2011 | 106 | 2011 |
